MDC are supporters of the SMR Radiopharmaceuticals event on Friday 4 September 2026, hosted in at AstraZeneca DISC, in Cambridge, UK
This meeting brings together industry and academic leaders to tackle discovery-to-development challenges, integrating insights from case studies, CMC and manufacturing, supply-chain resilience, and evolving regulatory expectations.
The programme will highlight design choices that influence efficacy and safety, spanning isotope selection, linker and vector engineering, and payload optimization. Attendees will gain practical insights into on drug design, radionuclide sourcing, and translation from concept to clinic.
Come and visit MDC at our booth at the event – more details to follow.
For more information and to register for the event click here
When: September 4, 2026
Where: Cambridge – AstraZeneca – The Discovery Centre (DISC), 1 Francis Crick Ave, Cambridge Biomedical Campus, CB2 0AA, UK
PACE (Pathways to Antimicrobial Clinical Efficacy) and the UK Health Security Agency (UKHSA) have released five new contemporary antimicrobial resistance (AMR) strain panels, giving innovators worldwide a resource to test novel therapeutics and diagnostics against today’s resistance patterns.
New appointments support MDC’s mission to turn drug discovery into commercial breakthroughs.
